Faced with a growing and increasingly elderly population, the health sector must adapt to the large number of patients and their needs, which are constantly evolving. Subject to continuous innovation, medical technologies can improve the quality of cares and provide assistance at all levels. Faster, simpler and more effective treatments also meet cost restriction needs, making it possible to reduce medical expenses for all (government, professionals and patients).
The medical technology market is growing rapidly and is expected to reach a turnover of $595 billion by 2024. This growth forecast of more than 5.6% over six years reflects the increasing demand in this industry driven in particular by the development of preventive medicine and patient autonomy, which are taking advantage of new technologies. In a constantly changing technological environment, industry leaders have shown a recurring appetite for financial transactions, with an average of between 230 and 270 mergers and acquisitions per year
The investment universe, consisting of approximately 220 stocks, includes the entire medical technology ecosystem throughout the healthcare chain. It aims to address the issues experienced by patients, medical staff and hospitals. We have identified different segments that can be classified into five main stages: prevention, diagnosis, intervention, treatment and medical follow-up.
We exclude from the universe companies that have the worst ESG records and average or high levels of controversies. ESG exclusion is based both on the overall record as well as on a set of criteria considered fundamental for the theme.